SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $18.6M invested in Salarius Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $17K

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$17K
Net Calls
Net Calls Change

Top Buyers

1
+$2.34M
2
+$260K
3
+$246K
4
Renaissance Technologies
Renaissance Technologies
New York
+$183K

Top Sellers

1
-$614K
2
-$386K
3
-$296K
4
Millennium Management
Millennium Management
New York
-$249K
5
PP
Paloma Partners
Connecticut
-$154K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4K
27
$1K
28
$24
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
1
2